definiens: means payments ( such as annual minimum royalties ) made by sublicensees to AMICUS to preserve, orto avoid a forfeiture of rights under, the sublicense agreement ; shall mean any Licensed Product other than a Core Licensed Product . Non - Core LicensedProducts include, but are not limited to, Licensed Products which are not for the treatment of Conformational Diseases, butare administered to increase the activity of endogenous wild - type proteins ; [ * * * ] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HASBEEN REQUESTED . ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES ANDEXCHANGE COMMISSION PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIESEXCHANGE ACT OF 1934, AS AMENDED 7 means all remuneration, other than royalties, received by AMICUS, including, but notlimited to, Contract Signature Payments, Third Party Milestone Payments and Maintenance Fees, but excludes : ( i ) payment or reimbursement for patent expenses incurred by AMICUS ; ( ii ) payment or reimbursement for the costs of research or development conducted by AMICUS that is sponsored bythird parties ; or ( iii ) purchases by third parties of AMICUS securities;and means payments made to AMICUS upon fulfillment by AMICUS or the sublicensee ofdesignated development objectives or regulatory requirements